Chlorityle Ointment offers a powerful and effective dual-action solution for common eye ailments, combining the broad-spectrum antibiotic Chloramphenicol (10mg) with the potent corticosteroid Hydrocortisone (5mg). This unique formulation is designed to treat bacterial eye infections while simultaneously reducing the associated inflammation, swelling, and redness. By addressing both the underlying cause and the symptoms, this ointment provides comprehensive relief and is a highly sought-after product by ophthalmologists for a wide range of conditions, from conjunctivitis to post-operative care.
The market for ophthalmology products in India is experiencing rapid and consistent growth, driven by an increasing number of eye infections, allergies, and the expansion of eye care clinics. A PCD pharma franchise for Chlorityle Ointment offers a prime opportunity for a stable and profitable business. The product's dual-action formula provides a significant competitive advantage in a high-demand market, ensuring a reliable revenue stream. We offer a monopoly-based business model in your designated territory, which protects you from internal competition and allows you to build a dominant position in the B2B supply chain for eye clinics and hospitals.
We are committed to empowering our franchise partners with all the tools they need for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality and efficacy, building trust with healthcare professionals. We provide extensive promotional and marketing support, including product literature, visual aids, and a dedicated sales team. Our robust supply chain guarantees timely delivery and consistent stock availability. Partner with us to enter this resilient market and establish a reputable and highly profitable business as a key supplier of a top-quality ophthalmic medication.